P10636 (TAU_HUMAN) Homo sapiens (Human)

Microtubule-associated protein tau UniProtKBInterProSTRINGInteractive Modelling

758 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6; Isoform 7; Isoform 8; Isoform 9); 1 identical sequence: Homo sapiens: A0A024R9Y1

Available Structures

131 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
tau-microtubule structural ensemble based on CryoEM data Heteromer
P02554; Q2XVP4;
519-712
GDP;GTP;MG;
Assess
tau-microtubule structural ensemble based on CryoEM data Heteromer
P02554; Q2XVP4;
519-712
GDP;GTP;MG;
Assess
Model of synthetic tau (R2x4) bound to the microtubule Heteromer
P02554; Q2XVP4;
591-617
GDP;GTP;MG;
Assess
Structure of tau peptide in complex with Tau5 antibody Fab fragment Heteromer
A2NHM3;
532-547
SO4;NA;PGE;
Assess
CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY PT3 Fab+pT212/pT217-TAU PEPTIDE Heteromer
527-539
GOL;
Assess
Crystal structure of anti-tau antibody dmCBTAU-28.1, double mutant (S32R, E35K) of CBTAU-28.1, in c… Heteromer
57-69
CL;
Assess
SOLUTION STRUCTURE OF PIN1 WW DOMAIN COMPLEXED WITH HUMAN TAU PHOSPHOTHREONINE PEPTIDE Heteromer
Q13526;
542-554
Assess
Crystal structure of human anti-tau antibody CBTAU-28.1 in complex with its tau peptide Heteromer
57-68
Assess
X-RAY STRUCTURE OF THE FAB FRAGMENT OF THE ANTI TAU ANTIBODY RB86 IN COMPLEX WITH THE PHOSPHORYLATE… Heteromer
736-747
Assess
Model of synthetic tau (four tandem repeats of first repeat sequence) bound to the microtubule Heteromer
P02554; Q2XVP4;
573-584
GTP;MG;GDP;
Assess
Crystal structure of anti-tau antibody dmCBTAU-27.1, double mutant (S31Y, T100I) of CBTAU-27.1, in … Heteromer
625-635
CL;
Assess
Structure of the anti-ptau Fab (pT231/pS235_1) in complex with phosphoepitope pT231/pS235 Heteromer
542-551
PO4;
Assess
anti-pTau C21-ABS Fab in complex with pTau peptide Heteromer
541-550
Assess
FAB CBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-5 Heteromer
735-744
GOL;
Assess
Anti-TAU AT8 FAB with doubly phosphorylated TAU peptide Heteromer
518-526
GOL;
Assess
Crystal structure of human anti-tau antibody CBTAU-24.1 in complex with its phosphorylated tau pept… Heteromer
552-560
Assess
Crystal structure of DC8E8 Fab in the complex with a 30-mer tau peptide at pH 6.5 Heteromer
Q52L64; Q99LC4;
615-623
Assess
Anti-TAU AT8 FAB with triply phosphorylated TAU peptide Heteromer
519-526
Assess
Anti-TAU BIIB092 FAB with TAU peptide Heteromer
A2NHM3;
15-22
Assess
Crystal structure of DC8E8 Fab in the complex with a 14-mer tau peptide at pH 8.5 Heteromer
615-622
GLC;PGE;
Assess
Crystal structure of human 14-3-3 sigma in complex with a Tau-protein peptide surrounding pS214 Heteromer
P31947;
528-535
CL;MG;CA;GOL;
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 126B with 14-3-3sigma Heteromer
P31947;
528-534
CL;
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 109B with 14-3-3sigma Heteromer
P31947;
528-534
49F;
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 201D with 14-3-3sigma Heteromer
P31947;
528-534
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 201D with 14-3-3sigma Heteromer
P31947;
528-534
49F;
Assess
Fab/epitope complex of mouse monoclonal antibody C5.2 targeting a phospho-tau epitope. Heteromer
709-715
PO4;
Assess
Crystal structure of DC8E8 Fab in the complex with a 14-mer tau peptide at pH 6.5 Heteromer
616-622
Assess
Crystal structure of Tau and acetylated tau peptide antigen Heteromer
594-600
Assess
Crystal structure of DC8E8 Fab in the complex with a 14-mer tau peptide at pH 7.5 Heteromer
616-622
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 4.2e-I with 14-3-3sigma Heteromer
P31947;
528-533
NA;D3W;CL;
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 4.2c-I with 14-3-3sigma Heteromer
P31947;
528-533
CL;MG;NA;D3K;
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 4.2f-I with 14-3-3sigma Heteromer
P31947;
528-533
NA;D3Q;CL;
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 4.2f-II with 14-3-3sigma Heteromer
P31947;
528-533
CL;NA;D4K;
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 4.2b with 14-3-3sigma Heteromer
P31947;
528-533
CL;NA;D4H;
Assess
The complex structure of PHF core domain peptide of tau and antibody's Fab domain. Heteromer
592-597
Assess
Fab/epitope complex of mouse monoclonal antibody 6B2 targeting a non-phosphorylated tau epitope. Heteromer
720-725
PO4;
Assess
Fab/epitope complex of human chimeric monoclonal antibody h4E6 targeting a phosphorylated tau epito… Heteromer
720-725
GOL;PO4;
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 3.2d with 14-3-3sigma Heteromer
P31947;
529-533
CL;MG;NA;60H;
Assess
Fab/epitope complex of mouse monoclonal antibody 8B2 targeting a non-phosphorylated tau epitope. Heteromer
721-725
GOL;PO4;
Assess
Crystal structure of human 14-3-3 sigma in complex with a Tau-protein peptide surrounding pS324 Heteromer
P31947;
640-643
MG;CA;CL;
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 3.2e with 14-3-3sigma Heteromer
P31947;
530-533
CA;CL;NA;60H;
Assess
KVQIINKKLD, Structure of the amyloid spine from microtubule associated protein tau Repeat 2homo-18-mer591-600
Assess
VQIINK, Structure of the amyloid-spine from microtubule associated protein tau Repeat 2homo-18-mer592-597
Assess
RNA-induced tau amyloid fibrilhomo-15-mer708-743
Assess
In vitro assembled 266/297 - 391 tau filaments with MgCl2 and NaCl (14b)homo-12-mer622-696
Assess
In vitro assembled 297-394 tau filaments, 700 rpm (34b)homo-12-mer621-695
Assess
In vitro assembled tau filaments into Quadruple Helical Filaments type 1 (2c)homo-12-mer621-695
Assess
Limbic-predominant neuronal inclusion body 4R tauopathy type 2 tau filamenthomo-10-mer589-696
Assess
Globular glial tauopathy type 2 tau filamenthomo-10-mer589-696
Assess
Globular glial tauopathy type 3 tau filamenthomo-10-mer589-696
Assess
Argyrophilic grain disease type 2 tau filamenthomo-10-mer591-698
Assess
Conformation 1 of straight filament from primary age-related tauopathy brainhomo-10-mer621-697
Assess
Conformation 2 of straight filament from primary age-related tauopathy brainhomo-10-mer621-697
Assess
Paired helical filament from primary age-related tauopathy brainhomo-10-mer621-697
Assess
Paired helical tau filament extracted from GSS Patient brain tissue | tau filament from Gerstmann S…homo-10-mer622-696
Assess
Tau Paired Helical Filament from Alzheimer's Disease incubated with EGCG for 3 hourshomo-10-mer622-696
10×KDH;
Assess
Tau Paired Helical Filament from Alzheimer's Disease not incubated with EGCGhomo-10-mer623-696
Assess
Tau Paired Helical Filament from Alzheimer's Disease incubated 1 hr. with EGCGhomo-10-mer623-696
Assess
Straight tau filament extracted from PrP-CAA Patient brain tissue | tau filament | SF Tauhomo-10-mer623-695
Assess
Pronase-treated paired helical filament in Alzheimer's disease brainhomo-10-mer623-695
Assess
Paired helical filament extracted from PrP-CAA Patient brain tissuehomo-10-mer623-695
Assess
Straight filament in Alzheimer's disease brainhomo-10-mer623-695
Assess
Paired helical filament in Alzheimer's disease brainhomo-10-mer623-695
Assess
KVQIINKKL, crystal structure of a tau protein fragmenthomo-10-mer591-599
Assess
SVQIVY, Crystal Structure of a tau protein fragmenthomo-10-mer622-627
Assess
In vitro assembled 266/297 - 391 tau filaments with KCl (10a)homo-9-mer623-696
18×CL; 18×K;
Assess
In vitro assembled tau filaments with MgSO4 and NaCl (15a)homo-9-mer626-694
Assess
In vitro assembled 305-379 tau filaments (27a)homo-9-mer624-634
Assess
MicroED structure of tau VQIVYK peptide at 1.1 A resolutionhomo-9-mer623-628
Assess
Structure of an amyloid forming peptide VQIVYK from the second repeat region of tau (alternate poly…homo-8-mer623-628
Assess
Doublet Tau Fibril from Corticobasal Degeneration Human Brain Tissuehomo-6-mer591-697
Assess
Cryo-EM structure of TypeII tau filaments extracted from the brains of individuals with Corticobasa…homo-6-mer591-697
Assess
In vitro assembled 266/297 - 391 tau filaments with KCl (10b)homo-6-mer622-705
Assess
Paired helical filament from sporadic Alzheimer's disease brainhomo-6-mer621-697
Assess
Straight filament from sporadic Alzheimer's disease brainhomo-6-mer621-697
Assess
In vitro assembled 266/297 - 391 tau filaments with ZnCl2 (11a)homo-6-mer621-696
Assess
In vitro assembled 266/297 - 391 tau filaments with NaHCO3 and NaCl (16a)homo-6-mer621-696
Assess
in vitro assembled tau filaments with structures like Paired Helical Filaments from Alzheimer's Dis…homo-6-mer621-696
Assess
in vitro assembled 266/297 - 391 tau filaments with MgCl2 and NaCl (14a)homo-6-mer621-696
Assess
In vitro assembled 297-408 S396D S400D T403D S404D tau filaments (42a)homo-6-mer621-696
Assess
Cryo-EM structure of in vitro PHF fibrilhomo-6-mer621-696
Assess
In vitro assembled 266/297 - 391 tau filaments with LiCl (9a)homo-6-mer622-696
Assess
In vitro assembled 297-394 tau filaments in PBS (35d)homo-6-mer622-696
Assess
In vitro assembled tau filaments with structures like chronic traumatic encephalopathy type II (8a)homo-6-mer622-696
Assess
Chronic traumatic encephalopathy Type II Tau filamenthomo-6-mer622-696
Assess
Chronic traumatic encephalopathy Type I Tau filamenthomo-6-mer622-696
Assess
Chronic traumatic encephalopathy tau filaments with PET ligand flortaucipirhomo-6-mer622-696
S9C;
Assess
In vitro assembled 266/297 - 391 tau filaments with LiCl (9b)homo-6-mer622-695
Assess
In vitro assembled 266/297 - 391 tau filaments with MgSO4 and NaCl (15b)homo-6-mer623-695
Assess
in vitro assembled 266/297 - 391 tau filaments with NaCl (8b)homo-6-mer625-695
Assess
In vitro assembled 300-391 tau filaments in PBS (36a)homo-6-mer625-695
Assess
In vitro assembled 266/297 - 391 tau filaments with MgSO4 and NaCl (15c)homo-6-mer626-694
Assess
In vitro assembled 0N4R tau filaments with phosphoserine (47a)homo-6-mer693-758
Assess
Cryo-EM structure of amyloid fibril formed by tau (297-391)homo-6-mer621-679
Assess
In vitro assembled 266/297 - 391 tau filaments with CuCl2 (12a)homo-6-mer622-677
Assess
In vitro assembled 266-391 S356D tau filaments with NaCl (45a)homo-6-mer591-645
Assess
In vitro assembled 266-391 S356D tau filaments with KCl (44a)homo-6-mer592-645
Assess
In vitro assembled 258-391 tau filaments with sodium azide, (41a)homo-6-mer594-634
Assess
Cryo-EM structure of heparin-induced 2N3R tau filamentshomo-6-mer620-647
Assess
Structure of an amyloid forming peptide VQIVYK from the TAU protein in complex with orange Ghomo-6-mer623-628
12×ZN;ACY;ORA;
Assess
RQEFEV, crystal structure of the N-terminal segment RQEFEV from protein tauhomo-6-mer5-10
Assess
Argyrophilic grain disease type 1 tau filamenthomo-5-mer590-704
Assess
Progressive supranuclear palsy tau filamenthomo-5-mer589-698
Assess
Limbic-predominant neuronal inclusion body 4R tauopathy type 1a tau filamenthomo-5-mer589-696
Assess
Globular glial tauopathy type 1 tau filamenthomo-5-mer589-696
Assess
Limbic-predominant neuronal inclusion body 4R tauopathy type 1b tau filamenthomo-5-mer589-696
Assess
Straight filament from Alzheimer's disease with PET ligand APN-1607homo-5-mer621-697
Assess
Paired helical filament from Alzheimer's disease with PET ligand APN-1607homo-5-mer621-697
Assess
Structure of an amyloid forming peptide VQIVYK from the repeat region of Tauhomo-4-mer623-628
Assess
High-resolution map of tau filament from progressive supranuclear palsy (PSP) case 1homo-3-mer589-698
Assess
Singlet Tau Fibril from Corticobasal Degeneration Human Brain Tissuehomo-3-mer591-697
Assess
Cryo-EM structure of TypeI tau filaments extracted from the brains of individuals with Corticobasal…homo-3-mer591-697
Assess
Narrow Pick Filament from Pick's disease brainhomo-3-mer602-695
Assess
In vitro assembled 258-391 tau filaments with phosphoglycerate, 700 rpm (39a)homo-3-mer621-696
Assess
In vitro assembled 266-391 tau filaments in PBS (23a)homo-3-mer623-695
Assess
In vitro assembled 258-391 tau filaments, 700 rpm (38a)homo-3-mer587-647
Assess
Cryo-EM structure of heparin-induced 2N4R tau snake filamentshomo-3-mer589-647
Assess
In vitro assembled 258-391 tau filaments with phosphoglycerate, 700 rpm (39a)homo-3-mer592-645
Assess
In vitro assembled 258-391 tau filaments with heparan sulfate, 700 rpm (40a)homo-3-mer592-645
Assess
In vitro assembled 244-391 tau filaments with Na2P2O7 (20a)homo-3-mer592-641
Assess
Cryo-EM structure of heparin-induced 2N4R tau jagged filamentshomo-3-mer591-638
Assess
Cryo-EM structure of heparin-induced 2N4R tau twister filamentshomo-3-mer591-638
Assess
Paired Helical Filament from Alzheimer's Disease Human Brain Tissuehomo-2-mer621-697
GLY;
Assess
Straight Filament from Alzheimer's Disease Human Brain Tissuehomo-2-mer621-697
GLY;
Assess
SVQIVYK segment from human Tau (305-311) displayed on 54-membered macrocycle scaffold (form II)homo-2-mer621-628
PO4;MPD;
Assess
SVQIVYK segment from human Tau (305-311) displayed on 54-membered macrocycle scaffold (form I)homo-2-mer621-628
PO4;
Assess
SVQIVYK segment from human Tau (305-311) displayed on 54-membered macrocycle scaffold (form III)homo-2-mer621-628
MPD;PO4;
Assess
Structure of Tau(267-312) bound to Microtubulesmonomer584-629
Assess
Structure of Tau(254-290) bound to F-actinmonomer571-607
Assess
Structure of Tau(292-319) bound to F-actinmonomer609-636
Assess
Structure of Tau(254-268) bound to F-actinmonomer571-585
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7mkf.1.Hmonomer0.57623-695
99.32
Assess
6gx5.1.Amonomer0.51603-695
92.47
Assess

8 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 27nrx.2.Amonomer0.51217-291
98.01
Assess
Isoform 36nwp.1.Dmonomer0.54184-254
99.67
Assess
Isoform 47nrt.1.Hmonomer0.51249-320
100.00
Assess
Isoform 56nwp.1.Dmonomer0.52278-348
100.00
Assess
Isoform 66nwp.1.Dmonomer0.51247-321
99.74
Assess
Isoform 76nwp.1.Dmonomer0.52276-350
100.00
Assess
Isoform 86nwp.1.Dmonomer0.50305-379
100.00
Assess
Isoform 97mkf.1.Hmonomer0.50641-713
99.09
Assess